Prelude Therapeutics Inc (PRLD)
3.12
+9.09%
Prelude Therapeutics Inc (PRLD) is currently trading at $3.12. This represents a gain of 9.09% from the previous session. With a market capitalization of $0.20B, PRLD is a key component of the Health Care sector. Investors looking to trade PRLD should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade PRLD commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Prelude Therapeutics Inc (PRLD) shows a bullish trend. Analysts are watching the 3.14 level closely.
Fundamentals
Mkt Cap0.20B
P/E Ratio0.0000
Volume6,881
60-Day Technical Chart
Advanced Charting
Need more indicators for PRLD? Use the world's #1 platform.
Open PRLD on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $3
| Metric |
PRLD +9.09% |
IRWD -10.42% |
EVH +12.89% |
AREC -0.31% |
|---|---|---|---|---|
| Price | $3.12 | $3.40 | $2.87 | $3.17 |
| Mkt Cap | $0.20B | $0.55B | $0.32B | $0.33B |
| - | View → | View → | View → |
Latest Headlines
FDA clears Prelude trial drug for polycythemia vera and myelofibrosis
Stock Titan • Feb 3, 2026
Retail investors in Prelude Therapeutics Incorporated (NASDAQ:PRLD) are its biggest bettors, and their bets paid off as stock gained 12% last week
Yahoo Finance • Jan 26, 2026
Why Did PRLD Stock Surge 13% Today?
Stocktwits • Feb 3, 2026
Prelude Therapeutics Incorporated's (NASDAQ:PRLD) 66% Share Price Plunge Could Signal Some Risk
simplywall.st • Dec 3, 2025
Prelude Therapeutics pauses clinical development of SMARCA2 degrader program (PRLD:NASDAQ)
Seeking Alpha • Nov 4, 2025
● Gemini Agentic AI Analyst Insight for PRLD
Market Education
- Long Short Strategy to Manage Risk May 31, 2024
- Investing $100: Options and Tools for Small Investments - many drops make an Ocean Jul 15, 2023
- Blackrock Top Stocks Nov 20, 2023
External Research